Lorimer IAJ - Search Results

1

Engineering PTEN-L for Cell-Mediated Delivery.

Lavictoire SJ, Gont A, Julian LM, Stanford WL, Vlasschaert C, Gray DA, Jomaa D, Lorimer IAJ. Lavictoire SJ, et al. Among authors: lorimer iaj. Mol Ther Methods Clin Dev. 2017 Nov 21;9:12-22. doi: 10.1016/j.omtm.2017.11.006. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2017. PMID: 29255742 Free PMC article.

2

Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe.

Lorimer IA, Lavictoire SJ. Lorimer IA, et al. J Immunol Methods. 2000 Apr 3;237(1-2):147-57. doi: 10.1016/s0022-1759(99)00219-7. J Immunol Methods. 2000. PMID: 10725459

3

Activation of extracellular-regulated kinases by normal and mutant EGF receptors.

Lorimer IA, Lavictoire SJ. Lorimer IA, et al. Biochim Biophys Acta. 2001 Feb 5;1538(1):1-9. doi: 10.1016/s0167-4889(00)00129-4. Biochim Biophys Acta. 2001. PMID: 11341977 Free article.

4

Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII.

Landry RC, Klimowicz AC, Lavictoire SJ, Borisova S, Kottachchi DT, Lorimer IA, Evans SV. Landry RC, et al. J Mol Biol. 2001 May 18;308(5):883-93. doi: 10.1006/jmbi.2001.4628. J Mol Biol. 2001. PMID: 11352579

5

Induction of apoptosis in glioblastoma cells by an atypical protein kinase C pseudosubstrate peptide.

Lorimer IA, Parolin DA, Lavictoire SJ. Lorimer IA, et al. Anticancer Res. 2002 Mar-Apr;22(2A):623-31. Anticancer Res. 2002. PMID: 12014630

6

Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII.

Lavictoire SJ, Parolin DA, Klimowicz AC, Kelly JF, Lorimer IA. Lavictoire SJ, et al. J Biol Chem. 2003 Feb 14;278(7):5292-9. doi: 10.1074/jbc.M209494200. Epub 2002 Dec 5. J Biol Chem. 2003. PMID: 12471035 Free article.

7

Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity.

Tsirigotis M, Baldwin RM, Tang MY, Lorimer IA, Gray DA. Tsirigotis M, et al. PLoS One. 2008 May 7;3(5):e2130. doi: 10.1371/journal.pone.0002130. PLoS One. 2008. PMID: 18461158 Free PMC article.

8

Coordination of glioblastoma cell motility by PKCι.

Baldwin RM, Barrett GM, Parolin DA, Gillies JK, Paget JA, Lavictoire SJ, Gray DA, Lorimer IA. Baldwin RM, et al. Mol Cancer. 2010 Sep 3;9:233. doi: 10.1186/1476-4598-9-233. Mol Cancer. 2010. PMID: 20815904 Free PMC article.

9

Repression of cancer cell senescence by PKCι.

Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard MA, Parolin DA, Lavictoire SJ, Amin MS, Islam S, Lorimer IA. Paget JA, et al. Oncogene. 2012 Aug 2;31(31):3584-96. doi: 10.1038/onc.2011.524. Epub 2011 Nov 28. Oncogene. 2012. PMID: 22120720

10

PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.

Gont A, Hanson JE, Lavictoire SJ, Parolin DA, Daneshmand M, Restall IJ, Soucie M, Nicholas G, Woulfe J, Kassam A, Da Silva VF, Lorimer IA. Gont A, et al. Oncotarget. 2013 Aug;4(8):1266-79. doi: 10.18632/oncotarget.1164. Oncotarget. 2013. PMID: 23907540 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page